Adicet Bio (ACET)
(Delayed Data from NSDQ)
$1.51 USD
0.00 (0.00%)
Updated Aug 1, 2024 04:00 PM ET
After-Market: $1.52 +0.01 (0.66%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Adicet Bio, Inc. [ACET]
Reports for Purchase
Showing records 101 - 108 ( 108 total )
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials, ADI-001 into the Clinic; Data in 2021
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
First Patient Dosed with ADI-001 with Data Expected by YE; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
ADI-001 IND Cleared With Study Startup in NHL Underway; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Initiating OUTPERFORM and $25 PT: Tooling a Unique T Cell for Tumors
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R